Takeda To Pay US$8.8bn For Millennium Pharmaceuticals

April 2008 | M&A News Alert

Japan's largest drug maker by revenue, Takeda Pharmaceuticals, has agreed to pay US$8.8bn for US drug maker Millennium Pharmaceuticals in the largest transaction involving a Japanese company this year. The purchase gives Takeda an entry into the lucrative and growing cancer medicine industry. The company will pay US$25 per share, a 68% premium on the 30-day average of Millennium's share price. CHART Millennium and Takeda

If you would like to subscribe to Corporate Financing Week and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Corporate Financing Week please click on the trial link below.